Detalhe da pesquisa
1.
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.
Int J Cancer
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380807
2.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 402(10415): 1835-1847, 2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871608
3.
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Liver Int
; 44(6): 1343-1350, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436529
4.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Oncologist
; 28(7): e526-e533, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023703
5.
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
Hepatol Res
; 53(5): 409-416, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601972
6.
Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma.
Hepatol Res
; 53(8): 749-760, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036153
7.
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.
BMC Cancer
; 22(1): 912, 2022 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999529
8.
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma.
BMC Cancer
; 22(1): 517, 2022 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525913
9.
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.
Hepatol Res
; 52(3): 269-280, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34761470
10.
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
J Hepatol
; 75(3): 600-609, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051329
11.
Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4-B1: a pilot study.
BMC Cancer
; 21(1): 1169, 2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717577
12.
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.
Hepatol Res
; 51(2): 201-215, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270323
13.
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.
Lancet Oncol
; 21(6): 808-820, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502443
14.
Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
Hepatology
; 69(6): 2533-2545, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805950
15.
Is platelet monitoring during 7-day lusutrombopag treatment necessary in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures? A phase IIIb open-label study.
Hepatol Res
; 50(10): 1141-1150, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32609920
16.
Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Int J Hyperthermia
; 37(1): 202-211, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32070164
17.
Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation.
Int J Hyperthermia
; 37(1): 1149-1158, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32996799
18.
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
J Med Ultrasound
; 28(2): 59-82, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32874864
19.
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
J Hepatol
; 71(3): 543-552, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176752
20.
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial.
BMC Cancer
; 19(1): 954, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615466